Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (5.405%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.80
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

Mon, 06th Mar 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Amur Minerals Corp, up 57% at 1.58 pence, 12-month range 0.6p-3.28p. The natural resources explorer completes the USD35 million disposal of 100% of its interest in AO Kun-Manie, to Bering Minerals. Kun-Manie is a wholly-owned subsidiary of Irosta, which is Amur's wholly-owned subsidiary. Will pay out a special dividend of 1.8p within 90 days of receipt of the sale funds. Back in November, Amur said it faced delays to the sale, due to restrictions on transferring funds to Russia. "We are pleased to have achieved the sale of Kun-Manie which will enable the company to move forward in a new direction, which we envision will result in shareholders seeing real value," says CEO Robin Young.

----------

Plexus Holdings PLC, up 40% at 4p, 12-month range 1.6p-6.2p. The engineering services provider secures an order for its wellhead equipment and sealing technology for a specialised project application. Under the GBP5 million contract, its Pos-Grip HG equipment and technology will be deployed over the next 12 months. About GBP2.5 million will be received via milestone payments in the current financial year ending June 30, with the remainder to be recognised as sales revenue in financial 2024. CEO Been van Bilderbeek says the contract "significantly increases the visibility of [the firm's] future revenue and cash flow projections, and Plexus' reputation as a "can do" surface or subsea equipment solutions provider.

----------

AIM - LOSERS

----------

Fusion Antibodies PLC, down 33% at 32p, 12-month range 30p-110p. The antibody developer says revenue and earnings for the year ending March 31 are expected to be "significantly" behind market expectations, with revenue to be no less than GBP2.8 million. This is due to continuing uncertainty over the timing of several anticipated orders, which is outside the firm's control. As Fusion shifts its focus on larger integrated service contracts, it notes "very positively received" discussions with several potential clients.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
17 Apr 2019 10:46

Fusion Antibodies revenues soar in strong second half

(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies reported a strong second half on Wednesday, driven by a significant increase in orders.

Read more
25 Feb 2019 11:56

Fusion Antibodies Guides For Revenue "Materially Below" Market Views

LONDON (Alliance News) - Fusion Antibodies PLC on Monday warned that annual revenue will be "materially below current market expectations" due to the uncertain timing of closure of were

Read more
25 Feb 2019 10:43

Fusion Antibodies dives as revenues falter

(Sharecast News) - Fusion Antibodies' shares plummeted on Monday after the company warned of failing revenues due to uncertainty surrounding the timing of "a number of potential substantial orders".

Read more
17 Dec 2018 14:51

Fusion Antibodies launches new 'RAMP' platform

(Sharecast News) - Pharmaceutical contract research organisation Fusion Antibodies launched its new 'Rational Affinity Maturation Platform' (RAMP) at the Antibody Engineering Conference in San Diego last week, it announced on Monday.

Read more
26 Nov 2018 10:39

Fusion Antibodies Interim Loss Widens On Increasing Competition

LONDON (Alliance News) - Fusion Antibodies PLC on Monday said that increasing competition, pricing pressures, and lower order levels have resulted in a substantial fall in revenue and a sharply of

Read more
26 Nov 2018 10:17

Fusion Antibodies sees losses widen throughout 'challenging' first half

(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies saw losses widen sharply throughout the first half of its trading year after revenues more than halved.

Read more
24 Sep 2018 17:03

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Buys Shares

LONDON (Alliance News) - Fusion Antibodies PLC said Monday Non-Executive Director Timothy Watts bought shares worth GBP10,237 in the life sciences firm in a transaction last Thursday.Watts

Read more
16 Aug 2018 13:40

Fusion Antibodies Posts Solid Revenue Rise But Warns On Current Trade

LONDON (Alliance News) - Fusion Antibodies PLC on Thursday said it has delivered strong annual revenue growth in a year in which it joined the London Stock Exchange's AIM market.The in

Read more
16 Aug 2018 08:10

Fusion Antibodies gets dragged to a loss as non-recurring items skyrocket

(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.

Read more
16 Aug 2018 08:10

Fusion Antibodies gets dragged to a loss as non-recurring items skyrocket

(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 10:26

Fusion Antibodies Shares Fall 30% After Profit Warning For New Year

LONDON (Alliance News) - Shares fell in Fusion Antibodies PLC on Monday as it reported that trading in its current financial year to date has been slower than expected, due to increase competition

Read more
13 Aug 2018 08:27

Fusion Antibodies shares tumble following downbeat outlook

(Sharecast News) - Fusion Antibodies shares crashed on Monday morning after the Belfast-based researcher revealed that year-to-date trading had been "slower than anticipated".

Read more
24 May 2018 14:59

Fusion Antibodies Receives Up To GBP213,000 Grant From Invest NI

LONDON (Alliance News) - Fusion Antibodies PLC said Thursday it received additional grants from regional business development agency Invest Northern Ireland of up to GBP213,000.The company

Read more
4 Apr 2018 08:00

Qatar's market manipulation fears fuelled by "abnormal" derivative moves-bank CEO

* Qatar c. bank probing market manipulation during Gulf standoff * Qatar's top bank helping central bank with probe * QNB says has cash

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.